|
1
|
Maruyama T, Kono K, Mizukami Y, Kawaguchi
Y, Mimura K, Watanabe M, Izawa S and Fujii H: Distribution of Th17
cells and FoxP3(+) regulatory T cells in tumor-infiltrating
lymphocytes, tumor-draining lymph nodes and peripheral blood
lymphocytes in patients with gastric cancer. Cancer Sci.
101:1947–1954. 2010.
|
|
2
|
Zhang Y, Ma D, Zhang Y, Tian Y, Wang X,
Qiao Y and Cui B: The imbalance of Th17/Treg in patients with
uterine cervical cancer. Clin Chim Acta. 412:894–900. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Korn T, Bettelli E, Oukka M and Kuchroo
VK: IL-17 and Th17 cells. Annu Rev Immunol. 27:485–517. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dong C: Diversification of T-helper-cell
lineages: finding the family root of IL-17-producing cells. Nat Rev
Immunol. 6:329–333. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ivanov II, McKenzie BS, Zhou L, Tadokoro
CE, Lepelley A, Lafaille JJ, Cua DJ and Littman DR: The orphan
nuclear receptor RORγt directs the differentiation program of
proinflammatory IL-17+ T helper cells. Cell.
126:1121–1133. 2006.
|
|
6
|
McGeachy MJ and Cua DJ: Th17 cell
differentiation: the long and winding road. Immunity. 28:445–453.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Manel N, Unutmaz D and Littman DR: The
differentiation of human T(H)-17 cells requires transforming growth
factor-beta and induction of the nuclear receptor RORγt. Nat
Immunol. 9:641–649. 2008.PubMed/NCBI
|
|
8
|
Volpe E, Servant N, Zollinger R, Bogiatzi
SI, Hupé P, Barillot E and Soumelis V: A critical function for
transforming growth factor-beta, interleukin 23 and proinflammatory
cytokines in driving and modulating human T(H)-17 responses. Nat
Immunol. 9:650–657. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang B, Rong G, Wei H, Zhang M, Bi J, Ma
L, Xue X, Wei G, Liu X and Fang G: The prevalence of Th17 cells in
patients with gastric cancer. Biochem Biophys Res Commun.
374:533–537. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sfanos KS, Bruno TC, Maris CH, Xu L,
Thoburn CJ, DeMarzo AM, Meeker AK, Isaacs WB and Drake CG:
Phenotypic analysis of prostate-infiltrating lymphocytes reveals
TH17 and Treg skewing. Clin Cancer Res. 14:3254–3261. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kryczek I, Wei S, Zou L, Altuwaijri S,
Szeliga W, Kolls J, Chang A and Zou W: Cutting edge: Th17 and
regulatory T cell dynamics and the regulation by IL-2 in the tumor
microenvironment. J Immunol. 178:6730–6733. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Su X, Ye J, Hsueh EC, Zhang Y, Hoft DF and
Peng G: Tumor microenvironments direct the recruitment and
expansion of human Th17 cells. J Immunol. 184:1630–1641. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang RF: Regulatory T cells and innate
immune regulation in tumor immunity. Springer Semin Immunopathol.
28:17–23. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nakamura T, Shima T, Saeki A, Hidaka T,
Nakashima A, Takikawa O and Saito S: Expression of indoleamine
2,3-dioxygenase and the recruitment of Foxp3-expressing regulatory
T cells in the development and progression of uterine cervical
cancer. Cancer Sci. 98:874–881. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wolf D, Wolf AM, Rumpold H, Fiegl H,
Zeimet AG, Muller-Holzner E, Deibl M, Gastl G, Gunsilius E and
Marth C: The expression of the regulatory T cell-specific forkhead
box transcription factor FoxP3 is associated with poor prognosis in
ovarian cancer. Clin Cancer Res. 11:8326–8331. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vernal R and Garcia-Sanz JA: Th17 and Treg
cells, two new lymphocyte subpopulations with a key role in the
immune response against infection. Infect Disord Drug Targets.
8:207–220. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kryczek I, Banerjee M, Cheng P, et al:
Phenotype, distribution, generation, and functional and clinical
relevance of Th17 cells in the human tumor environments. Blood.
114:1141–1149. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Miyahara Y, Odunsi K, Chen W, Peng G,
Matsuzaki J and Wang RF: Generation and regulation of human
CD4+ IL-17-producing T cells in ovarian cancer. Proc
Natl Acad Sci USA. 105:15505–15510. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Beyer M and Schultze JL: Regulatory T
cells in cancer. Blood. 108:804–811. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Byrne WL, Mills KH, Lederer JA and
O’Sullivan GC: Targeting regulatory T cells in cancer. Cancer Res.
71:6915–6920. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shen S, Liang L, Peng BG, He Q, Kuang M
and Lai JM: Foxp3+ regulatory T cells and the formation
of portal vein tumor thrombus in patients with hepatocellular
carcinoma. Can J Surg. 54:89–94. 2011.
|
|
22
|
Xu L, Xu W, Qiu S and Xiong S: Enrichment
of CCR6+Foxp3+ regulatory T cells in the
tumor mass correlates with impaired CD8+ T cell function
and poor prognosis of breast cancer. Clin Immunol. 135:466–475.
2010.PubMed/NCBI
|
|
23
|
Miller AM, Lundberg K, Ozenci V, Banham
AH, Hellström M, Egevad L and Pisa P:
CD4+CD25high T cells are enriched in the
tumor and peripheral blood of prostate cancer patients. J Immunol.
177:7398–7405. 2006.
|
|
24
|
Curiel TJ, Coukos G, Zou L, et al:
Specific recruitment of regulatory T cells in ovarian carcinoma
fosters immune privilege and predicts reduced survival. Nat Med.
10:942–949. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Acosta-Rodriguez EV, Napolitani G,
Lanzavecchia A and Sallusto F: Interleukins 1beta and 6 but not
transforming growth factor-beta are essential for the
differentiation of interleukin 17-producing human T helper cells.
Nat Immunol. 8:942–949. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wilson NJ, Boniface K, Chan JR, et al:
Development, cytokine profile and function of human interleukin
17-producing helper T cells. Nat Immunol. 8:950–957. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bettelli E, Carrier Y, Gao W, Korn T,
Strom TB, Oukka M, Weiner HL and Kuchroo VK: Reciprocal
developmental pathways for the generation of pathogenic effector
TH17 and regulatory T cells. Nature. 441:235–238. 2006. View Article : Google Scholar
|
|
28
|
Mangan PR, Harrington LE, O’Quinn DB,
Helms WS, Bullard DC, Elson CO, Hatton RD, Wahl SM, Schoeb TR and
Weaver CT: Transforming growth factor-beta induces development of
the T(H)17 lineage. Nature. 441:231–234. 2006. View Article : Google Scholar
|
|
29
|
Veldhoen M, Hocking RJ, Atkins CJ,
Locksley RM and Stockinger B: TGFbeta in the context of an
inflammatory cytokine milieu supports de novo differentiation of
IL-17-producing T cells. Immunity. 24:179–189. 2006. View Article : Google Scholar
|
|
30
|
Stritesky GL, Yeh N and Kaplan MH: IL-23
promotes maintenance but not commitment to the Th17 lineage. J
Immunol. 181:5948–5955. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang L, Anderson DE, Baecher-Allan C,
Hastings WD, Bettelli E, Oukka M, Kuchroo VK and Hafler DA: IL-21
and TGF-beta are required for differentiation of human T(H)17
cells. Nature. 454:350–352. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ichihara F, Kono K, Takahashi A, Kawaida
H, Sugai H and Fujii H: Increased populations of regulatory T cells
in peripheral blood and tumor-infiltrating lymphocytes in patient
with gastric and esophageal cancers. Clin Cancer Res. 9:4404–4408.
2003.PubMed/NCBI
|
|
33
|
Sasada T, Kimura M, Yoshida Y, Kanai M and
Takabayashi A: CD4+CD25+ regulatory T cells
in patients with gastrointestinal malignancies: possible
involvement of regulatory T cells in disease progression. Cancer.
98:1089–1099. 2003.
|
|
34
|
Bouchliou I, Miltiades P, Nakou E, et al:
Th17 and Foxp3(+) T regulatory cell dynamics and distribution in
myelodysplastic syndromes. Clin Immunol. 139:350–359. 2011.
|
|
35
|
Hou F, Li Z, Ma D, Zhang W, Zhang Y, Zhang
T, Kong B and Cui B: Distribution of Th17 cells and
Foxp3-expressing T cells in tumor-infiltrating lymphocytes in
patients with uterine cervical cancer. Clin Chim Acta.
413:1848–1854. 2012. View Article : Google Scholar : PubMed/NCBI
|
